Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.